| 摘要 |
The present invention is related to intermediates for the preparation of new bafilomycin and concanamycin macrolides, which bafilomycin and concanamycin macrolides are useful for the inhibition of bone resorption and the treatment of bone affecting diseases. The said intermediates are of formula (I). |
